Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Levenson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Cancer Research|August 1, 1997
MCF-7: the first hormone-responsive breast cancer cell lineA S Levenson, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|March 11, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Cancer Research|May 15, 1998
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptorA S Levenson, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1994
Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell linesA S Levenson, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptorA S Levenson, W H Catherino, V C Jordan
British Journal of Cancer|July 17, 1998
The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptorA S Levenson, D A Tonetti, V C Jordan
Cancer Letters|May 5, 1998
Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cellsA S Levenson, K M Svoboda, H C Kwaan, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1995
Differential expression of gas and gadd genes at distinct growth arrest points during adipocyte developmentE C Shugart, A S Levenson, C M Constance, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 2001
Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cellsJ MacGregor Schafer, H Liu, A S Levenson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Cancer Research|August 1, 1997
MCF-7: the first hormone-responsive breast cancer cell lineA S Levenson, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|March 11, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Cancer Research|May 15, 1998
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptorA S Levenson, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1994
Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell linesA S Levenson, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptorA S Levenson, W H Catherino, V C Jordan
British Journal of Cancer|July 17, 1998
The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptorA S Levenson, D A Tonetti, V C Jordan
Cancer Letters|May 5, 1998
Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cellsA S Levenson, K M Svoboda, H C Kwaan, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1995
Differential expression of gas and gadd genes at distinct growth arrest points during adipocyte developmentE C Shugart, A S Levenson, C M Constance, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 2001
Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cellsJ MacGregor Schafer, H Liu, A S Levenson, et al.
Pageof 2